The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2010 |
| Author/s |
author: François Guilhot Delphine Rea |
| Publication date | December 10, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |